Navigation Links
Inverness Medical Innovations to Present at the JMP Securities Healthcare Focus Conference on October 6, 2009
Date:9/30/2009

WALTHAM, Mass., Sept. 30 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the JMP Securities Healthcare Focus Conference being held on October 5 and 6, 2009 at The New York Palace Hotel. Jon Russell, Vice President, Finance, will attend. Mr. Russell's presentation is scheduled for Tuesday, October 6, 2009 at 10:30 a.m.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

SOURCE Inverness Medical Innovations, Inc.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Inverness Medical Innovations, Inc. Announces Offering of $100 Million of Senior Notes
2. Inverness Medical Innovations Announces September Investor Conference Schedule
3. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
4. Inverness Medical Innovations to Present at the Canaccord Adams Global Growth Conference on August 11, 2009
5. Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes
6. CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients
7. Inverness Medical Innovations Announces Second Quarter 2009 Results
8. Inverness Medical Innovations Proposes to Acquire Concateno plc
9. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
10. Inverness Medical Innovations to Present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009
11. Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 02, 2015 Thermi, formerly ThermiAesthetics, ... has successfully transitioned into its new company headquarters ... the company’s continued rapid worldwide expansion and houses ... over 25 Thermi employees, including those of the ... , “As one of the fastest growing aesthetic ...
(Date:6/2/2015)... 02, 2015 Each year, Cosmetic Executive ... Beauty Awards. This year, the organization’s members – 8,000 ... of the QVC® Beauty Quest Award at the 2015 ... Emulsion (ME) Technology and 2-in-1 approach to skincare differentiated ... the brand’s loyal consumer and professional fan bases, QVC ...
(Date:6/2/2015)... 02, 2015 Atlantic Spine Center ... surgery with three locations in New Jersey, announces the ... The new facility is at 1045 Park Avenue (at ... and appointments can be arranged by calling 1-844-912-2406. ... Atlantic Spine Center, has been a pioneer in the ...
(Date:6/2/2015)... Mt. View, CA (PRWEB) June 02, 2015 ... state mandated vaccination schedule for children to attend public ... Health, Judiciary and Education but bypassed the Appropriations Committee ... Senate floor 25-10 despite contentious hearings. , “We ... with Personal Belief Exemptions (PBEs) more than it will ...
(Date:6/2/2015)... 2015 Specialty Technical Publishers, premier ... risk solutions , and Radar today announced the ... gap-improvement program. , All organizations need to resolve ... Organizations not only assess and treat risks (managing ... this (risk managing) thereby embedding these capabilities within ...
Breaking Medicine News(10 mins):Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:Scalisi Skincare Wins Coveted CEW QVC Beauty Quest Award for Innovative and Patented Formulation 2Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:A Voice For Choice Releases A Statement As SB277 Is Referred To Single Assembly Committee And Bypasses Education and Judicial Scrutiny 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4
... of HIV infection than non-smokers, reveals an analysis ... the journal Sexually Transmitted// Infections. ,Cigarette ... than normal chance of contracting other infections generally, ... ,The researchers trawled through 13 academic research ...
... American Dental Association (ADA) reported that serious damage of oral ... This drug harms the ability of chewing.// ,The ... over 12 million Americans have used methamphetamine, also called meth, ... or smoked. Most of the users are of the age ...
... and Hezbollah in Lebanon made a normally tense situation ... Emanuel Hanski, HHMI// international research scholars from Israel, have ... lab to join the military, not knowing when or ... tanks to check up on their research," says Michaeli. ...
... of Medicine researchers have found high rates of hunger ... western North Carolina,// southwestern Virginia and Forsyth County. ... of hunger, there are segments of the N.C. population ... areas of persistent poverty like Appalachia,” said Sara A. ...
... study has indicated that the Human papillomavirus (HPV) could ... Human papillomavirus is// associated with the growth of warts, ... ,Researchers from New York Hospital-Cornell Medical ... had only a 50% chance of conception through the ...
... here Monday in his bid to complete 24 such runs in ... cancer// research. ,"The 'Great World Run' is my greatest ... run 314.4 miles between Sep 7 and Oct 1, and travel ... final run will be at Newcastle upon Tyne in Britain Oct ...
Cached Medicine News:Health News:Methamphetamine causes severe oral health damage 2Health News:Surveys Find Outright Hunger among Latino Immigrants in North Carolina 2Health News:Surveys Find Outright Hunger among Latino Immigrants in North Carolina 3
(Date:6/2/2015)... SAN FRANCISCO , June 2, 2015  Nektar ... Texas MD Anderson Cancer Center today announced a research ... evaluate NKTR-214, a CD122-biased cytokine designed to preferentially stimulate ... cells found naturally in the body.  CD122, which is ... a key signaling receptor that is known to increase ...
(Date:6/2/2015)... , June 2, 2015 Northstar ... first television and multi-media commercial advertisement, which it ... to promote SNORenz®, the company,s top selling product. ... the company,s past success with television advertising. Previous ... but this, more modern version takes an entertainment-oriented ...
(Date:6/2/2015)... und MADRID , ... Mündliche Präsentation (Abstract   10503), vorgestellt ... Clinical Oncology    PharmaMar teilt ... ( Janssen) Daten der multizentrischen Phase-3-Studie ... Verbesserung beim progressionsfreien Überleben (progression-free survival, PFS) ...
Breaking Medicine Technology:Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 2Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 3Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 4Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 5Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 6Northstar releases its direct response multi-media ad designed to be used in national television advertising campaigns 2PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 2PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 3PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 4PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 5PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 6
... Ltd. (NYSE Amex: CPD ) announced that ... (Sun) have been extended until January 28, 2012 but ... which was originally set to expire in January 2010, ... and is being extended for an additional 1 year ...
... Pharmaceutical Company (NYSE: KVa/KVb) today announced the filing of its ... with the Securities and Exchange Commission.  As a result, the ... 2010 Form 10-K to enable its securities to continue trading ... is currently working on preparing and filing its quarterly reports ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma 2Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma 3K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 2K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 3K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 4K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 5K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 6K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 7K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 8
... are packaged in single-use foil-laminated ... is saturated with precisely the ... package is terminally sterilized, ensuring ... the patient. Swabstick provides excellent ...
... All Povidone Iodine 'Prep' ... skin and mucous membrane ... procedures. All Povidone Iodine ... solutions with surfactants. Each ...
... BETADINE Solution ... of 10% povidone-iodine. It ... antiseptic that kills gram-positive ... antibiotic resistant organisms), as ...
... This multi-purpose topical gel contains 10% Povidone ... germicidal action. As a pre-operative prep, Povidone ... of prepping solutions under the patient, thus ... Gel is also approved as a one ...
Medicine Products: